We are an AI-native clinical imaging services company focused on CROs and BioPharma organizations running Phase I–III trials. Our credentialed clinical teams deliver end-to-end imaging execution — reads, adjudication, QA, and regulatory-grade audit trails — powered by ONIX AI, our purpose-built orchestration platform for clinical imaging research.

🔬 For CROs: One accountable imaging partner. One SLA. One audit trail. Reduce read turnaround by 30–40% without adding compliance risk. Our hybrid onshore/offshore delivery model brings 25–40% cost efficiency versus legacy imaging CROs — with no compromise on GCP or 21 CFR Part 11 standards.

🧬 For Emerging Biopharma: You're building a pipeline drug, not an imaging operation. We handle the entire imaging layer — from study setup to final read — so your team stays focused on the science. Transparent pricing. Named clinical leads. Setup in days.

⚙️ ONIX AI Platform: Protocol-driven workflow automation. Intelligent case routing. Multi-reader adjudication. Full audit trail. Human-in-the-loop governance designed for FDA submissions.

🌏 Global Delivery: Credentialed subspecialty reader network across the U.S. and India. 24-hour read coverage. Equivalent board certifications. Identical QA protocols enforced by ONIX AI — regardless of geography.

Beyond imaging, GenPhase brings deep AI build and scale expertise to life sciences — helping organizations implement, govern, and operationalize AI across clinical and commercial functions.

The modern alternative to legacy imaging CROs. Built for the teams changing medicine.

📩 Connect with us: hello@genphase.ai
www.genphase.ai

GenPhase.ai

Org chart

Teams

Offices